XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.

XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.
C
C

CSX

Haberler

Reuters - 5 gün önce

Canada railways warn of Aug. 22 lockout without labor deal

UPDATE 4-Canada railways warn of Aug. 22 lockout without labor deal Adds request by CN for federal intervention, comments from union paragraphs 1, 4-5, 8 OTTAWA, Aug 9 (Reuters) - C anada's two main rail companies said on Friday they would lock out employees on Aug. 22 if talks to negotiate a labor contract fail , a move that would bring the country's transport of goods to a halt .
C
Reuters - 1 hafta önce

U.S. STOCKS Lumen Technologies, Broadridge Financial, IDEXX

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Broadridge Financial, IDEXX Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
C
I
U
U
F
M
R
T
U
B
J
M
Reuters - 1 hafta önce

CSX rises after Q2 profit tops expectations

BUZZ-CSX rises after Q2 profit tops expectations ** CSX Corp's CSX.O shares up 2% at $33.67 premarket after U.S. railroad operator's qtrly earnings surpass expectations ** Q2 adj EPS of 49 cents beat consensus by a penny, per LSEG, as co benefited from higher shipment volumes, robust pricing ** Rev of $3.7 bln in qtr inline with Street ** JP Morgan, which rates CSX "overweight", boosted its PT by $3 to $42 ** CSX will outperform rail peers after Q2 results were "significantly better than expecte
C
U
Reuters - 1 hafta önce

U.S. Actinium, Albemarle, ArcBest

U.S. RESEARCH ROUNDUP- Actinium, Albemarle, ArcBest Aug 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Actinium Pharmaceuticals, Albemarle and ArcBest, on Tuesday. HIGHLIGHTS * Actinium Pharmaceuticals Inc ATNM.A : JonesTrading cuts PT to $9 from $26 * Albemarle ALB.N : Baird cuts to neutral; cuts target price to $85 from $102 * ArcBest Corp ARCB.O : Stephens cuts target price to $130 from $145 * Crispr Therapeuti
A
A
B
B
C
C
C
C
D
Reuters - 1 hafta önce

CSX beats second-quarter profit on better volumes, strong pricing

CSX beats second-quarter profit on better volumes, strong pricing Aug 5 (Reuters) - U.S. railroad operator CSX CSX.O narrowly beat second-quarter profit estimates on Monday, helped by higher shipment volumes and robust pricing, sending its shares up 5% after the bell. Improving intermodal volumes, or goods moved via two or more modes of transport, have helped railroads squeeze out profits along with higher-than-inflation pricing, even as the overall freight industry continues to face a downturn.
C
Reuters - 1 hafta önce

CSX Corp reports results for the quarter ended in June - Earnings Summary

CSX Corp reports results for the quarter ended in June - Earnings Summary CSX Corp CSX.OQ reported quarterly adjusted earnings of 49 cents​​ per share for the quarter ended in June, identical to the same quarter last year. The mean expectation of twenty three analysts for the quarter was for earnings of 48 cents per share. Wall Street expected results to range from 46 cents to 49 cents per share.
C
Reuters - 1 hafta önce

CSX Q2 EPS USD 0.49 Vs. IBES Estimate USD 0.48

BRIEF-CSX Q2 EPS USD 0.49 Vs. IBES Estimate USD 0.48 Aug 05 (Reuters) - CSX Q2 operating income USD 1,450 million vs. IBES estimate USD 1,410 million. Q2 net income USD 963 million vs. IBES estimate USD 935.8 million Q2 revenue USD 3,700 million vs. IBES estimate USD 3,702 million
C
Reuters - 1 hafta önce

PREVIEW: CSX dips ahead of report; analysts see rev, EPS mostly flat

BUZZ-PREVIEW: CSX dips ahead of report; analysts see rev, EPS mostly flat ** Shares of CSX Corp CSX.O down 2.4% on Mon ahead of qtrly results after the bell, with analysts expecting essentially flat rev from the U.S. railroad operator as investors fret about a weakening U.S. economy ** CSX now down 4% YTD, vs S&P 500's .SPX 9% increase ** Analysts
C
U
Reuters - 3 hafta önce

Higher pricing, volumes seen easing hit from slowing coal demand for US rail firms

PREVIEW-Higher pricing, volumes seen easing hit from slowing coal demand for US rail firms By Abhinav Parmar July 24 (Reuters) - A pick up in intermodal and vehicle shipment volumes combined with higher pricing are expected to blunt the impact from slowing coal demand on second-quarter earnings for US railroad companies. There has been a sequential improvement in industry carloads, led by intermodal, which involves shipping goods via two or more modes of transportation, and automotive shipments,
C
Reuters - 1 ay önce

TD Cowen lowers profit estimates for top U.S. railroads on lower volumes

BUZZ-TD Cowen lowers profit estimates for top U.S. railroads on lower volumes ** Brokerage TD Cowen lowers Q2 profit estimates for U.S. railroads Union Pacific UNP.N , CSX Corp CSX.O and Norfolk Southern NSC.N and price targets for the latter two ** Brokerage says quarter-to-date volumes hauled by the railroads are below consensus, adding that "rail volumes continue to track below pre-COVID levels" ** "We modestly lower our volume assumptions in Q2 for the U.S.
C
Reuters - 1 ay önce

U.S. Acelyrin, Blue Owl Capital, Malibu Boats

U.S. RESEARCH ROUNDUP-Acelyrin, Blue Owl Capital, Malibu Boats July 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acelyrin, Blue Owl Capital and Malibu Boats, on Monday. HIGHLIGHTS * Acelyrin Inc SLRN.O : Wells Fargo raises to overweight from equal-weight * Blue Owl Capital Inc OWL.N : TD Cowen cuts to hold from buy * J B Hunt Transport Services Inc JBHT.O : Stephens initiates with overweight rating * Malibu Boat
A
A
C
C
G
G
U
G
A
A
A
A
R
Reuters - 2 ay önce

Norfolk Southern falls, analyst cuts PT, NTSB suggests safety changes

BUZZ-Norfolk Southern falls, analyst cuts PT, NTSB suggests safety changes Updates prices, adds DJT, transport peer prices ** Shared in Norfolk Southern NSC.N down ~4 % on Tues, leading declines in Dow Jones Transport Average index .DJT , down 1 .6%; analyst cuts PT while National Transportation Safety Board h eld a hearing o n Febr uary 2023 NSC Ohio train derailment * * NTSB making sweeping recommendations to boost rail safety after derailment that forced residents to temporarily abandon homes
C
J
Reuters - 2 ay önce

Canadian truckers well positioned to benefit in case of rail strike, Ryder Systems says

Canadian truckers well positioned to benefit in case of rail strike, Ryder Systems says By Abhinav Parmar June 20 (Reuters) - Canadian transportation services provider Ryder Systems R.N said the trucking market should be able to handle a jump in freight volume in the event of a rail strike, though it signaled that the cost of shipping may increase.
C
Reuters - 3 ay önce

Reuters Events: CSX fully resuming Baltimore coal exports this week, CEO says

Reuters Events: CSX fully resuming Baltimore coal exports this week, CEO says By Lisa Baertlein ATLANTA, May 22 (Reuters) - CSX CSX.O this week will return to normal coal export operations at the Port of Baltimore after work crews cleared part of the deep channel serving the second busiest U.S. trade hub for outgoing coal shipments, the railroad's CEO said on Wednesday.
C
Reuters - 3 ay önce

CPKC to resume contract negotiations with Canadian rail workers union

UPDATE 4-CPKC to resume contract negotiations with Canadian rail workers union Adds statement from union in paragraphs 11 to 13 May 16 (Reuters) - Canadian Pacific Kansas City (CPKC) CP.TO said on Thursday its leadership, with the assistance of federal mediators, will resume contract negotiations with the Teamsters Canada Rail Conference (TCRC) union on May 17. CPKC and the union will meet in an effort to achieve a new collective agreement for the company's train and engine and rail traffic cont
C

Şartlar

Popüler varlıklar

Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.

Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.

Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.

Risk uyarısı: Sermayeniz risk altında. Kaldıraçlı ürünler herkese uygun olmayabilir. Lütfen Risk Bildirimi'mizi dikkate alın.